Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

Nature medicine·2026
Same author

The fly brain lands in Tokyo: A report on the 3rd Asia Pacific Drosophila Neurobiology Conference.

Genes to cells : devoted to molecular & cellular mechanisms·2024
Same author

Study of Dendrite Differentiation Using <i>Drosophila</i> Dendritic Arborization Neurons.

Cold Spring Harbor protocols·2023
Same author

Mounting of Embryos, Larvae, and Pupae for Live <i>Drosophila</i> Dendritic Arborization Neuron Imaging.

Cold Spring Harbor protocols·2023
Same author

Use of DeTerm for Automated <i>Drosophila</i> Dendrite Arbor Terminal Counts.

Cold Spring Harbor protocols·2023
Same author

Mosaic Analysis with a Repressible Cell Marker (MARCM) Clone Generation in <i>Drosophila</i> Dendritic Arborization Neurons.

Cold Spring Harbor protocols·2023

Related Experiment Video

Updated: May 10, 2026

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
11:06

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Published on: March 21, 2017

An MLL-dependent network sustains hematopoiesis.

Erika L Artinger1, Bibhu P Mishra, Kristin M Zaffuto

  • 1Department of Genetics , Institute for Quantitative Biomedical Sciences, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.

Proceedings of the National Academy of Sciences of the United States of America
|June 8, 2013
PubMed
Summary

The histone methyltransferase Mixed Lineage Leukemia (MLL) regulates genes beyond Hox targets in hematopoietic stem cells. PR domain containing 16 partially rescues MLL-deficient cells, revealing MLL

Keywords:
HSCepigeneticsproliferation

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
11:06

Combining Intravital Fluorescent Microscopy (IVFM) with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches

Published on: March 21, 2017

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Area of Science:

  • Molecular Biology
  • Hematopoiesis
  • Epigenetics

Background:

  • Mixed Lineage Leukemia (MLL) is crucial for hematopoietic stem cell maintenance and is implicated in leukemia.
  • While MLL's role in regulating Hox genes is known, its broader transcriptional network in normal hematopoiesis is uncharacterized.

Purpose of the Study:

  • To identify and characterize the MLL-dependent transcriptional network in hematopoietic stem cells.
  • To understand the distinctions between MLL's function in normal hematopoiesis and its role in leukemia.

Main Methods:

  • Utilized conditional loss-of-function models.
  • Performed genomewide expression analyses.
  • Conducted chromatin immunoprecipitation and functional rescue assays.

Main Results:

  • The MLL-dependent transcriptional network extends beyond previously known Hox targets.
  • Identified regulators of self-renewal within the MLL network, with both Menin-dependent and -independent targets.
  • PR domain containing 16 showed unique efficacy in rescuing MLL-deficient hematopoietic stem and progenitor cells.

Conclusions:

  • Highlights the tissue-specific regulatory roles of MLL/Trithorax family members.
  • Provides insights into MLL's distinct roles in normal hematopoiesis versus leukemia development.